147 related articles for article (PubMed ID: 30416852)
1. Novel nano-drug combination therapeutic regimen demonstrates significant efficacy in the transgenic mouse model of pancreatic ductal adenocarcinoma.
Thakkar A; Desai P; Chenreddy S; Modi J; Thio A; Khamas W; Ann D; Wang J; Prabhu S
Am J Cancer Res; 2018; 8(10):2005-2019. PubMed ID: 30416852
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen.
Sutaria D; Grandhi BK; Thakkar A; Wang J; Prabhu S
Int J Oncol; 2012 Dec; 41(6):2260-8. PubMed ID: 23007664
[TBL] [Abstract][Full Text] [Related]
3. Preclinical systemic toxicity evaluation of chitosan-solid lipid nanoparticle-encapsulated aspirin and curcumin in combination with free sulforaphane in BALB/c mice.
Thakkar A; Chenreddy S; Thio A; Khamas W; Wang J; Prabhu S
Int J Nanomedicine; 2016; 11():3265-76. PubMed ID: 27499621
[TBL] [Abstract][Full Text] [Related]
4. Ferulic acid combined with aspirin demonstrates chemopreventive potential towards pancreatic cancer when delivered using chitosan-coated solid-lipid nanoparticles.
Thakkar A; Chenreddy S; Wang J; Prabhu S
Cell Biosci; 2015; 5():46. PubMed ID: 26301084
[TBL] [Abstract][Full Text] [Related]
5. A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions.
Grandhi BK; Thakkar A; Wang J; Prabhu S
Cancer Prev Res (Phila); 2013 Oct; 6(10):1015-1025. PubMed ID: 24072676
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of ibuprofen loaded solid lipid nanoparticles and its combination regimens for pancreatic cancer chemoprevention.
Thakkar A; Chenreddy S; Wang J; Prabhu S
Int J Oncol; 2015 Apr; 46(4):1827-34. PubMed ID: 25652350
[TBL] [Abstract][Full Text] [Related]
7. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
[TBL] [Abstract][Full Text] [Related]
8. The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models.
Shen R; Wang Q; Cheng S; Liu T; Jiang H; Zhu J; Wu Y; Wang L
Cancer Lett; 2013 Oct; 339(1):135-43. PubMed ID: 23887057
[TBL] [Abstract][Full Text] [Related]
9. The molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancer.
Thakkar A; Sutaria D; Grandhi BK; Wang J; Prabhu S
Oncol Rep; 2013 Apr; 29(4):1671-7. PubMed ID: 23404329
[TBL] [Abstract][Full Text] [Related]
10. Expression of neuropeptide Y and its receptors Y1 and Y2 in pancreatic intraepithelial neoplasia and invasive pancreatic cancer in a transgenic mouse model and human samples of pancreatic cancer.
Waldmann J; Fendrich V; Reichert M; Hecker A; Bartsch DK; Padberg W; Holler JPN
J Surg Res; 2018 Mar; 223():230-236. PubMed ID: 29433879
[TBL] [Abstract][Full Text] [Related]
11. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer.
Fendrich V; Sparn M; Lauth M; Knoop R; Plassmeier L; Bartsch DK; Waldmann J
Pancreatology; 2013; 13(5):502-7. PubMed ID: 24075515
[TBL] [Abstract][Full Text] [Related]
13. miR-216 and miR-217 expression is reduced in transgenic mouse models of pancreatic adenocarcinoma, knockout of miR-216/miR-217 host gene is embryonic lethal.
Azevedo-Pouly AC; Sutaria DS; Jiang J; Elgamal OA; Amari F; Allard D; Grippo PJ; Coppola V; Schmittgen TD
Funct Integr Genomics; 2017 May; 17(2-3):203-212. PubMed ID: 27541609
[TBL] [Abstract][Full Text] [Related]
14. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.
Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I
J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419
[TBL] [Abstract][Full Text] [Related]
15. Increased Bcl-xL Expression in Pancreatic Neoplasia Promotes Carcinogenesis by Inhibiting Senescence and Apoptosis.
Ikezawa K; Hikita H; Shigekawa M; Iwahashi K; Eguchi H; Sakamori R; Tatsumi T; Takehara T
Cell Mol Gastroenterol Hepatol; 2017 Jul; 4(1):185-200.e1. PubMed ID: 28948203
[TBL] [Abstract][Full Text] [Related]
16. A genetically engineered mouse model developing rapid progressive pancreatic ductal adenocarcinoma.
Yamaguchi T; Ikehara S; Nakanishi H; Ikehara Y
J Pathol; 2014 Oct; 234(2):228-38. PubMed ID: 25042889
[TBL] [Abstract][Full Text] [Related]
17. GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm.
Taki K; Ohmuraya M; Tanji E; Komatsu H; Hashimoto D; Semba K; Araki K; Kawaguchi Y; Baba H; Furukawa T
Oncogene; 2016 May; 35(18):2407-12. PubMed ID: 26257060
[TBL] [Abstract][Full Text] [Related]
18. [Mouse models for human colorectal cancer with liver metastasis].
Huang XD; Zheng YB; Yang YJ; Yang C; Li HL; Cheng HR
Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(34):2701-2705. PubMed ID: 31505723
[No Abstract] [Full Text] [Related]
19. Anti-inflammatory activity of curcumin-loaded solid lipid nanoparticles in IL-1β transgenic mice subjected to the lipopolysaccharide-induced sepsis.
Wang J; Wang H; Zhu R; Liu Q; Fei J; Wang S
Biomaterials; 2015; 53():475-83. PubMed ID: 25890744
[TBL] [Abstract][Full Text] [Related]
20. Calorie restriction delays the progression of lesions to pancreatic cancer in the LSL-KrasG12D; Pdx-1/Cre mouse model of pancreatic cancer.
Lanza-Jacoby S; Yan G; Radice G; LePhong C; Baliff J; Hess R
Exp Biol Med (Maywood); 2013 Jul; 238(7):787-97. PubMed ID: 23828595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
